[The choice of appropriate thrombolytic agents as therapy in acute heart infarct].
Görge
G
G
II. Medizinische Klinik, Johannes-Gutenberg-Universität, Mainz.
Meyer
J
J
D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary; D016255:Anistreplase / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004792:Enzyme Precursors / Q000008:administration & dosage; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D010960:Plasminogen Activators / Q000008:administration & dosage; D011994:Recombinant Proteins; D013300:Streptokinase / Q000008:administration & dosage; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D000925:Anticoagulants; D004792:Enzyme Precursors; D011994:Recombinant Proteins; D016255:Anistreplase; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator; C067551:saruplase
Die Wahl geeigneter Thrombolytika zur Therapie des akuten Herzinfarktes.